gdc
Multiple MyelomaSlideshowsWeb Exclusives

Multiple Myeloma

March is multiple myeloma month. Check out our slideshow on this cancer type.

Web Exclusives – March 28, 2017

  • Centers For Disease Control Co 768x512

    March is Multiple Myeloma Awareness Month. Here are some risk factors and statistics related to the disease.

  • Diverse Group 768x512

    In 2017, an estimated 30,280 new cases of multiple myeloma will be diagnosed, including 17,490 men and 12,790 women.

    Source: The American Cancer Society
  • Senior Couple On Bicycles 768x512

    Multiple myeloma is more than twice as common in African Americans as in white Americans.

    Source: The American Cancer Society
  • Mother Grown Son 768x512

    People who have a sibling or parent with multiple myeloma are 4 times more likely to have the disease.

    Source: The American Cancer Society
  • Mm Cells 768x512

    This disease is the second most common blood cancer in the world.

    Source: International Myeloma Foundation
  • Cq Logo

    To read more about multiple myeloma, check out our articles here.  

Recommended For You
LeukemiaNewsworthyWeb Exclusives
Quizartinib Significantly Improves Survival Over Chemotherapy in Patients with Relapsed/Refractory AML and FLT3-ITD Mutation
This is the first treatment that targets patients with AML and the FLT3-ITD mutation. In this clinical trial, patients who received quizartinib lived longer without disease progression than those receiving chemotherapy.
MelanomaSlideshowsWeb Exclusives
Skin Cancer Awareness Month
May is Skin Cancer Awareness Month! View this slideshow to learn the latest statistics in the United States, leading causes and preventive measures, and quick facts on melanoma, one of the most common types of skin cancer. Conquer cancer with knowledge.
Financial SupportMultiple MyelomaSupport Services
Financial Support Services for Patients with Multiple Myeloma
The following financial support services are available for patients with multiple myeloma. For more information, see the full 2018 Patient Guide to Cancer Support Services.
Breast CancerNewsworthyWeb Exclusives
Breaking News: Sellas Announces Promising Data on NeuVax in Combination with Herceptin in HER2 1+/2+ Breast Cancer
NeuVax + Herceptin may provide a clinically meaningful benefit to breast cancer patients with low to intermediate HER2-expression.
Last modified: October 3, 2017

Subscribe to CONQUER: the patient voice® magazine

Receive timely cancer news & updates, patient stories, and more.

Country